UTY-specific TCR-transfer generates potential graft-versus-leukaemia effector T cells

British Journal of Haematology

Volumn 129, Issue 3, 2005, Pages 392-402

  Ivanov, Roman ^a   Hol, Samantha ^a   Aarts, Tineke ^a   Hagenbeek, Anton ^a   Slager, Elisabeth H ^b   Ebeling, Saskia ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Donor lymphocyte infusion; Graft versus leukaemia; H Y antigens; Immunotherapy; T cell receptor transfer

Indexed keywords

EPITOPE; HLA B ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; EFFECTOR CELL; FIBROBLAST; GENE; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; HUMAN CELL; IMMUNOTHERAPY; LYMPHOBLAST; PRIORITY JOURNAL; T LYMPHOCYTE; UTY GENE;

CELL CULTURE TECHNIQUES; CELL PROLIFERATION; EPITOPES, T-LYMPHOCYTE; FEASIBILITY STUDIES; GRAFT VS LEUKEMIA EFFECT; HLA-B ANTIGENS; HUMANS; INTERFERON TYPE II; LYMPHOCYTE TRANSFUSION; MALE; PEPTIDE FRAGMENTS; PROTEINS; RECEPTORS, ANTIGEN, T-CELL; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION;

EID: 18444394636     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05461.x     Document Type: Article

References (32)

1. Arden, B., Clark, S.P., Kabelitz, D. & Mak, T.W. (1995) Human T-cell receptor variable gene segment families. Immunogenetics, 42, 455-500.
2. Barrett, J. (2003) Allogeneic stem cell transplantation for chronic myeloid leukemia. Seminars in Hematology, 40, 59-71.
3. Blatch, G.L. & Lassle, M. (1999) The tetratricopeptide repeat: a structural motif mediating protein-protein interactions. Bioessays, 21, 932-939.
4. Clay, T.M., Custer, M.C., Sachs, J., Hwu, P., Rosenberg, S.A. & Nishimura, M.I. (1999) Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity. Journal of Immunology, 163, 507-513.
5. + CML progenitor cells. British Journal of Haematology, 121, 721-729.
6. Goulmy, E., Schipper, R., Pool, J., Blokland, E., Falkenburg, J.H., Vossen, J., Gratwohl, A., Vogelsang, G.B., van Houwelingen, H.C. & van Rood, J.J. (1996) Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. New England Journal of Medicine, 334, 281-285.
7. Heemskerk, M.H., Hoogeboom, M., Hagedoorn, R., Kester, M.G., Willemze, R. & Falkenburg, J.H. (2004) Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer. Journal of Experimental Medicine, 199, 885-894.
8. Imanishi, T., Akaza, T., Kimura, A., Tokunaga, K. & Gojobori, T. (1992) Allele and Haplotype Frequencies for HLA and Complement Loci in Various Ethnic Groups. Oxford University Press, Oxford, pp. 1065-1220.
9. Ivanov, R., Aarts, T., Hagenbeek, A., Hol, S. & Ebeling, S. (2005a) B-cell expansion in the presence of the novel 293-CD40L-sCD40L cell line allows the generation of large numbers of efficient xenoantigen-free APC. Cytotherapy, 7, 62-73.
10. Ivanov, R., Aarts, T., Hol, S., Doornenbal, A., Hagenbeek, A., Petersen, E. & Ebeling, S. (2005b) Identification of a 40S ribosomal protein S4-derived H-Y epitope able to elicit a lymphoblast-specific cytotoxic T lymphocyte response. Clinical Cancer Research, 11, 1694-1703.
11. Jiang, Y.Z., Mavroudis, D.A., Dermime, S., Molldrem, J., Hensel, N.F. & Barrett, A.J. (1997) Preferential usage of T cell receptor (TCR) V beta by allogeneic T cells recognizing myeloid leukemia cells: implications for separating graft-versus-leukemia effect from graft-versus-host disease. Bone Marrow Transplantation, 19, 899-903.
12. Kolb, H.J., Schmid, C, Barrett, A.J. & Schendel, D.J. (2004) Graft-versus-leukemia reactions in allogeneic chimeras. Blood, 103, 767-776.
13. Liu, X., Peralta, E.A., Ellenhorn, J.D. & Diamond, D.J. (2000) Targeting of human p53-overexpressing tumor cells by an HLA A*0201- restricted murine T-cell receptor expressed in Jurkat T cells. Cancer Research, 60, 693-701.
14. + T cells by virtue of their receptor beta loci sequences. Proceedings of the National Academy of Sciences of the U.S.A, 100, 1180-1184.
15. Morgan, R.A., Dudley, M.E., Yu, Y.Y., Zheng, Z., Robbins, P.P., Theoret, M.R., Wunderlich, J.R., Hughes, M.S., Restifo, N.P. & Rosenberg, S.A. (2003) High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens. Journal of Immunology, 171, 3287-3295.
16. Onishi, M., Kinoshita, S., Morikawa, Y., Shibuya, A., Phillips, J., Lanier, L.L., Gorman, D.M., Nolan, G.P., Miyajima, A. & Kitamura, T. (1996) Applications of retrovirus-mediated expression cloning. Experimental Hematology, 24, 324-329.
17. Pierce, R.A., Field, E.D., den Haan, J.M., Caldwell, J.A., White, F.M., Marto, J.A., Wang, W., Frost, L.M., Blokland, E., Reinhardus, C., Shabanowitz, J., Hunt, D.F., Goulmy, E. & Engelhard, V.H. (1999) Cutting edge: the HLA-A*0101-restricted H-Y minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique. Journal of Immunology, 163, 6360-6364.
18. Rammensee, H.G., Friede, T. & Stevanoviic, S. (1995) MHC ligands and peptide motifs: first listing. Immunogenetics, 41, 178-228.
19. Randolph, S.S., Gooley, T.A., Warren, E.H., Appelbaum, F.R. & Riddell, S.R. (2004) Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood, 103, 347-352.
20. Rock, K.L., York, I.A. & Goldberg, A.L. (2004) Post-proteasomal antigen processing for major histocompatibility complex class I presentation. Nature Immunology, 5, 670-677.
21. Rubinstein, M.P., Kadima, A.N., Salem, M.L., Nguyen, C.L., Gillanders, W.E., Nishimura, M.I. & Cole, D.J. (2003) Transfer of TCR genes into mature T cells is accompanied by the maintenance of parental T cell avidity. Journal of Immunology, 170, 1209-1217.
22. Schaft, N., Willemsen, R.A., de Vries, J., Lankiewicz, B., Essers, B.W., Gratama, J.W., Figdor, C.G., Bolhuis, R.L., Debets, R. & Adema, G.J. (2003) Peptide fine specificity of anti-glycoprotein 100 CTL is preserved following transfer of engineered TCR alpha beta genes into primary human T lymphocytes. Journal of Immunology, 170, 2186-2194.
23. Schumacher, T.N. (2002) T-cell-receptor gene therapy. Nature Reviews Immunology, 2, 512-519.
24. Scott, D.M., Ehrmann, I.E., Ellis, P.S., Chandler, P.R. & Simpson, E. (1997) Why do some females reject males? The molecular basis for male-specific graft rejection. Journal of Molecular Medicine, 75, 103-114.
25. Skaletsky, H., Kuroda-Kawaguchi, T., Minx, P.J., Cordum, H.S., Hillier, L., Brown, L.G., Repping, S., Pyntikova, T., Ali, J., Bieri, T., Chinwalla, A., Delehaunty, A., Delehaunty, K., Du, H., Fewell, G., Fulton, L., Fulton, R., Graves, T., Hou, S.F., Latrielle, P., Leonard, S., Mardis, E., Maupin, R., McPherson, J., Miner, T., Nash, W., Nguyen, C., Ozersky, P., Pepin, K., Rock, S., Rohlfing, T., Scott, K., Schultz, B., Strong, C., Tin-Wollam, A., Yang, S.P., Waterston, R.H., Wilson, R.K., Rozen, S. & Page, D.C. (2003) The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature, 423, 825-837.
26. Stanislawski, T., Voss, R.H., Lotz, C., Sadovnikova, E., Willemsen, R.A., Kuball, J., Ruppert, T., Bolhuis, R.L., Melief, C.J., Huber, C., Stauss, H.J. & Theobald, M. (2001) Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer. Nature Immunology, 2, 962-970.
27. Sureda, A. & Schmitz, N. (2003) Allogeneic stem cell transplantation after reduced-intensity conditioning in lymphoid malignancies. Annals of Hematology, 82, 1-13.
28. Vogt, M.H., Goulmy, E., Kloosterboer, P.M., Blokland, E., de Paus, R.A., Willemze, R. & Falkenburg, J.H. (2000) UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition. Blood, 96, 3126-3132.
29. Vogt, M.H., van den Muijsenberg, J.W., Goulmy, E., Spierings, E., Kluck, P., Kester, M.G., van Soest, R.A., Drijfhout, J.W., Willemze, R. & Falkenburg, J.H. (2002) The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease. Blood, 99, 3027-3032.
30. Wang, W., Meadows, L.R., den Haan, J.M., Sherman, N.B., Chen, Y., Blokland, E., Shabanowitz, J., Agulnik, A.I., Hendrickson, R.C. & Bishop, C.E. (1995) Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science, 269, 1588-1590.
31. Warren, E.H., Gavin, M.A., Simpson, E., Chandler, P., Page, D.C., Disteche, C., Stankey, K.A., Greenberg, P.D. & Riddell, S.R. (2000) The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen. Journal of Immunology, 164, 2807-2814.
32. Weijtens, M., van Spronsen, A., Hagenbeek, A., Braakman, E. & Martens, A. (2002) Reduced graft-versus-host disease-inducing capacity of T cells after activation, culturing, and magnetic cell sorting selection in an allogeneic bone marrow transplantation model in rats. Human Gene Therapy, 13, 187-198.